Netherlands· NL-9b63d7b8a01c

Imatinib 1A Pharma 400 mg, filmomhulde tabletten

A imatinib product containing imatinibmesilaat, registered in Netherlands by 1A Pharma GmbH. The same ATC class is registered in 15 of our 19 countries.

ATC L01EA01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about imatinibmesilaatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Imatinib is registered in 15 of 19 countries.

Countries holding a registration under ATC L01EA01 (imatinib), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search imatinib products by name

Imatinib · ATC L01EA01

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of imatinib costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $2.80 in United States to $41.72 in Switzerland — a ×15 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Imatinib · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

CH Switzerland$41.72
IT Italy$11.38
US United States$2.80 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: IMATINIBMESILAAT
Manufacturer: 1A Pharma GmbH
Country: Netherlands (NL)
ATC code: L01EA01
ATC class: Imatinib
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
133541

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

766 interactions on record for imatinib.

Graded by severity as the source publishes them — 114 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check imatinib against other medicines How interaction checks work

Imatinib · interactions on record

766 records

114 severe
518 moderate
23 minor
111 info

Most severe, free to view

CisaprideA03FA02severe
NaloxegolA06AH03severe
EliglustatA16AX10severe
LonafarnibA16AX20severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Imatinib in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All imatinib products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Imagerolan, Imatinib 1a Pharma
Belgium · Imatinib Eg, Imatinib Grindeks
Bulgaria · Иматиниб Тева Фарма, Меаксин
Cyprus · Imarem, Imatinib Koanaa 100 Mg
Czechia · Imanivec, Imatinib Grindeks
Germany · Imanivec, Imatinib 1 A Pharma
Denmark · Bimatix, Imatinib "sandoz"
Estonia · Glipox, Imatinib Grindeks
Spain · Imatinib Cipla, Imatinib Farmalider
Finland · Bimatix, Imatinib Hexal
France · Imatinib Arrow Lab, Imatinib Bgr
United Kingdom (Northern Ireland) · Imatinib, Imatinib Amarox
Greece · Imatek, Imatinib Aenorasis
Croatia · Imakrebin, Meaxin
Hungary · Imaniver, Imatinib 1 A Pharma
Ireland · Imatinib Krka D.D., Imatinib Rowex
Iceland · Bimatix, Glivec
Italy · Imanivec, Imatinib Dr. Reddy’s
Liechtenstein · Glivec, Imatinib Accord
Lithuania · Glipox, Imatinib Grindeks
Luxembourg · Imatinib, Imatinib Eg
Latvia · Imatinib Grindeks, Imatinib Inteli
Malta · Imatinib Tad, Nibix
Norway · Bimatix, Glivec
Poland · Imatenil, Meaxin
Portugal · Imatinib Aurobindo, Imatinib Aurovitas
Romania · Imakrebin, Imatinib Grindeks
Sweden · Bimatix, Imatinib Amarox
Slovenia · Meaxin
Slovakia · Imatinib Glenmark, Imatinib Grindeks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f98138b1-0075-418d-af6d-f273f072b835
GET /v1/drugs/f98138b1-0075-418d-af6d-f273f072b835?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h133541_smpc_en.pdf",
  "strength": null,
  "atc_label": "Imatinib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg133541",
  "excipients": [
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "MACROGOL 8000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "IMATINIBMESILAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h133541_piluk.pdf",
  "authorised_at": "2026/08/17",
  "procedure_number": "NL/H/6194/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "133541",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about imatinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console